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Manuel A. Rivas,2 Mark J. Daly,2 Gerd Schmitz,3 Andrew A. Hicks,6 Thomas Meitinger,9 Lars Feuk,1
Cornelia van Duijn,4 Ben Oostra,5 Peter P. Pramstaller,6,7,8 Igor Rudan,10,11 Alan F. Wright,12
James F. Wilson,11 Harry Campbell,11 and Ulf Gyllensten1,*
Omega-3 and omega-6 long-chain polyunsaturated fatty acids (LC-PUFAs) are essential for the development and function of the human
brain. They can be obtained directly from food, e.g., fish, or synthesized from precursor molecules found in vegetable oils. To determine
the importance of genetic variability to fatty-acid biosynthesis, we studied FADS1 and FADS2, which encode rate-limiting enzymes for
fatty-acid conversion. We performed genome-wide genotyping (n ¼ 5,652 individuals) and targeted resequencing (n ¼ 960 individuals)
of the FADS region in five European population cohorts. We also analyzed available genomic data from human populations, archaic
hominins, and more distant primates. Our results show that present-day humans have two common FADS haplotypes—defined by
28 closely linked SNPs across 38.9 kb—that differ dramatically in their ability to generate LC-PUFAs. No independent effects on FADS
activity were seen for rare SNPs detected by targeted resequencing. The more efficient, evolutionarily derived haplotype appeared after
the lineage split leading to modern humans and Neanderthals and shows evidence of positive selection. This human-specific haplotype
increases the efficiency of synthesizing essential long-chain fatty acids from precursors and thereby might have provided an advantage
in environments with limited access to dietary LC-PUFAs. In the modern world, this haplotype has been associated with lifestyle-related
diseases, such as coronary artery disease.Introduction
The proportionally large human brain relative to body size
is unique among primates, and a large portion of the
resting-energy budget is allocated to the brain to support
it.1 In order to maintain the function of our brain and
central nervous system, humans are highly dependent
on high amounts of two long-chain polyunsaturated fatty
acids (LC-PUFAs), the omega-3 docosahexaenoic acid
(DHA) and the omega-6 arachidonic acid (AA).2,3 These
fatty acids are essential to humans in the sense that they
cannot be synthesized de novo but need to be supplied
through dietary intake, either as DHA and AA or as their
18-carbon precursors, alpha-linolenic acid (ALA) and lino-
leic acid (LA). DHA is mainly found in fish, whereas AA is
also present in egg, land-animal fats, and liver. The precur-
sors LA and ALA are found in high quantities in some vege-
table oils.4 The conversion of the 18-carbon precursors to
LC-PUFAs is done through a series of elongations and desa-
turations of the fatty-acid molecules. The d-5 and d-6 fatty-
acid desaturases, which introduce double bonds after the
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The Amcarboxyl end of the carbon chain, are rate-limiting
enzymes in the biosynthesis of omega-3 and omega-6
LC-PUFAs.5 These two key enzymes are encoded by
FADS1 (MIM 606148) and FADS2 (MIM 606149), respec-
tively, located in a head-to-head orientation on chromo-
some 11.
SNPs in the FADS region have previously been shown to
have strong association with levels of blood lipids6–10 and
LC-PUFAs.11–14 The variation in the FADS loci has also
been shown to modulate breast-feeding effects on intelli-
gence development15 and modify the transfer of DHA
and AA from the mother to the child,16,17 and it has
been associated with increased risks of inflammation and
coronary artery disease.18
Despite the great interest in the FADS region as a key
locus for LC-PUFA biosynthesis, there are until now no
studies that have investigated the potential role of FADS
mutations in human evolution. The greater encephaliza-
tion of modern humans might have required genetic
adaptations of the fatty-acid metabolism to satisfy the
high demand of LC-PUFAs needed to sustain the larger
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efficiency of converting the precursors ALA and LA to
longer fatty acids are likely to be favored in environments
with limited dietary access to these LC-PUFAs.
In order to elucidate the effect of genetic variants in the
FADS region on the production of LC-PUFAs, we combined
genotyped and imputed SNPs data with resequencing of
the FADS1 and FADS2 loci and estimates of the synthesis
of LC-PUFAs in local European populations. The popula-
tion-sequencing data allowed us to investigate the inde-
pendent effect of rare variants, an issue that has been the
focus of much interest.21 We also analyzed available
genomic data from contemporary human populations,
archaic hominins, and more distant primates to gain
insight into the evolutionary history of the FADS region.
Our results show that in humans, two common and very
distinct FADS haplotypes are strongly associated with LC-
PUFA-synthesis levels. The haplotype associated with the
enhanced ability to produce AA and DHA from their
precursors is specific to humans and has appeared after
the split of the common ancestor of humans and Neander-
thals. This haplotype shows evidence of positive selection
in African populations, in which it is presently almost
fixed; the haplotype is less frequent outside Africa. We
propose that the haplotype that provides a more efficient
synthesis of LC-PUFAs might act as a thrifty genotype
and represents a risk factor for lifestyle-related diseases,
such as coronary artery disease.Material and Methods
Population Sample
The cohorts studied are from populations in Sweden, Italy,
Scotland, Croatia, and The Netherlands and are part of the
European Special Population Research Network (EUROSPAN).
The Northern Swedish Population Health Study (NSPHS) is
a cross-sectional study conducted in the community of Kare-
suando, north of the Arctic Circle in Norrbotten County,
Sweden.22 The Orkney Complex Disease Study (ORCADES) is
a longitudinal study in the Scottish archipelago of Orkney.23 The
VIS study is a cross-sectional study in the villages of Vis and
Komiza on the Dalmatian island of Vis, Croatia.24,25 TheMicroiso-
lates in South Tyrol Study (MICROS) is a cross-sectional study
carried out in Venosta Valley, South Tyrol, Italy.26 The Erasmus
Rucphen Family Study (ERF) is a longitudinal study of a population
that has been living in the Rucphen region, The Netherlands since
the 19th century.27 More information on the EUROSPAN popula-
tions has been published previously.22 All participants gave their
written informed consent,28 and the projects were approved by
the institutional review boards in each country.Lipidomics
As part of the EUROSPAN project, a large number of lipids were
measured by mass spectrometry (ESI-MS/MS) in positive-ion
mode as described previously.29,30 In particular, phospholipids
including phosphatidylcholine (PC) have been quantified in
over 4,000 individuals from the five populations.31 PC 36:4 used
here is a subgroup of phospholipids containing 36 carbons and
four double bonds. Specific fatty acids (e.g., components of the810 The American Journal of Human Genetics 90, 809–820, May 4, 2omega-3 and omega-6 biosynthesis) were quantified for 700 indi-
viduals from the NSPHS cohort.
SNP Array Genotyping and Imputation
DNA samples were genotyped according to the manufac-
turer’s instructions on Illumina Infinium HumanHap300 or
HumanCNV370 SNP bead microarrays as described previously.7
Analysis of the raw data was performed with BeadStudio software
according to the recommended parameters for the Infinium assay
and with the genotype cluster files provided by Illumina. Samples
with a call rate <97%, identical twins, and genetic outliers (identi-
fied by classical multidimensional scaling) were excluded from the
analysis. Population stratifications were also tested for by multidi-
mensional scaling. In the initial quality control, the primary anal-
ysis included most SNPs except for those deviating strongly form
the Hardy-Weinberg equilibrium (p value < 1010). MaCH32 and
reference haplotypes from the 1,000 Genomes Database (release
2010-08) were used for performing SNP imputation for a 2.7 Mb
region centered over the FADS region. The EUROSPAN genotype
data were phased with fastPhase.33 The following are the amounts
of individualswithcomplete genotypeand imputationdata in each
cohort: 2,385 from ERF, 795 from VIS, 1,097 from MICROS, 719
from ORCADES, and 656 from NSPHS.
SNP Association Analysis and Haplotype
Reconstruction
Association analyses of the quantitative lipid measurements were
performed with the R package GenABEL.34 This tool was devel-
oped to enable statistic analyses of genetic data in related individ-
uals with the use of a mixed model.35 Meta-analyses of data from
the five populations were carried out with MetABEL.34 We used
Haploview36 to examine the association between high and low
levels of the lipid PC 36:4 and all SNPs with a call rate above
75%. This resulted in a list of 134 SNPs (see Table S1, available on-
line). The associated haplotypes were constructed by the following
procedure. Starting with all 134 SNPs in the region, we iteratively
removed SNPs for which (1) the two alleles were found on
different haplotypes with the same effect on PC 36:4 and (2) the
same allele was found inmultiple haplotypes with different effects
on PC 36:4. For each round of this analysis, we considered only the
haplotypes present in at least 3% of the chromosomes. This re-
sulted in 28 strongly associated SNPs on two common haplotypes
accounting for over 95% of the chromosomes. The calculation of
p values for individual markers was performed in Haploview with
the use of a chi-square test based on allele frequencies between
the case and control groups (highest and lowest levels of PC
36:4). The detected haplotype frequencies (for A, D, and mixed)
did not deviate from the Hardy-Weinberg equilibrium (chi-square
test, p value > 0.9) in any of the five populations or in a combina-
tion of the five.
Enrichment and Resequencing of the FADS Region
From each of the five population cohorts, we selected 90–100
unrelated individuals with the lowest levels of PC 36:4 and the
same number of individuals with the highest levels of PC 36:4.
We pooled equal amounts of genomic DNA from each individual
into a high-lipid and a low-lipid pool for each population at a final
DNA concentration of 10 ng/ml. The procedure for genomic
enrichment and sequencing has been described previously.37
The FADS region (hg18, chr11: 61,311,035–61,390,653) was
covered by 26 amplicons. The average amplicon was about 2 kb012
and had 50–100 nucleotides that overlapped. As a result of repet-
itive sequences, some parts of the 80 kb region could not be
covered by amplicons.
We carried out long-range PCR in the Veriti thermal cycler
(Applied Biosystems) by using 50 ng DNA from the pool in a reac-
tion volume of 100 ml containing 53 HF buffer, 200 mM dNTPs,
12 mM of each primer, and 1 unit of Phusion high fidelity poly-
merase (Finnzymes, Finland). A two-step PCR was performed
with an initial denaturation for 30 s at 98C; this initial denatur-
ation was followed by 30 cycles of denaturation for 10 s at 98C,
an extension for 90 s at 72C, and a final extension at 72C for
10 min. Amplicons were purified with the QIAGEN Clean-up kit
(QIAquick, QIAGEN Nordic, Sweden), the concentration was
determined with NanoDrop (NanoDrop Technologies), and an
equal copy number of each amplicon was used in an amplicon
pool. We used the amplicon pool from a population to generate
a fragment library, and we sequenced this by using 50 bp reads
on the SOLiD3 system.
Analysis of Sequence Reads
The SOLiD system-analysis pipeline tool (corona lite) was used for
the alignment of the SOLiD reads to a reference consisting of the
DNA sequence in the FADS region; up to four mismatches were
allowed for each 50 bp read. SNP identification and estimation
of allele frequencies in the resequenced pools of individuals were
performed as described earlier.37
Analysis and Validation of Rare Variants in the FADS
Region
The analysis of rare variants was carried out with the C-alpha
statistic as recently described.38 This resulted in 24 rare SNPs
that showed significant differences between the individuals with
high and low levels of PC 36:4 (Table S3). Fourteen of these 24
SNPs were validated with TaqMan genotyping assays on the indi-
vidual DNA samples. The assays included 1,308 individuals from
four of the populations: 459 from VIS, 192 from ERF, 160 from
MICROS, and 497 fromNSPHS. For VIS and NSPHS, a cross-section
of all individuals was selected and included those that were rese-
quenced in the high and low pools. For ERF and MICROS, only
the individuals from the pooled resequencing were included.
Analysis of Effects of Rare Variants with Respect
to Haplotypes A and D
In order to elucidate the independent effects of rare variants, we
stratified the data on the basis of the haplotypes of the 1,308 gen-
otyped individuals (AA or DD). The allele frequencies for the rare
SNPs ranged between 0.04 and 0.50 for the 180 AA individuals.
For the 492 individuals in the DD group, the corresponding allele
frequencies were considerably lower (0–0.004). Thus, the rare vari-
ants are predominantly found on haplotype A. Among individuals
homozygous for haplotype A, no statistically significant effect was
detected for any of the 14 rare variants (p > 0.1, Wilcoxon-rank
sum test, one-sided).
Analysis of the Geographical Distribution of the Two
FADS Haplotypes
We used genotype data from all individuals present in CEPH-
obtained samples from the Human Genome Diversity Panel39
(HGDP; 2008, final release) to study the frequencies of haplotypes
A and D in native populations distributed all over the world. Four
of the 28 SNPs that distinguish between the two haplotypes wereThe Ampresent in the HGDP data. Each chromosome in the HGDP data
was classed as haplotype A, D, or mixed on the basis of the four
genotyped SNPs. A similar analysis was performed for individuals
of African (ASW [African ancestry in Southwest USA], LWK
[Luhya in Webuye, Kenya], and YRI [Yoruba in Ibadan, Nigeria]),
European (FIN [Finnish in Finland), GBR [British from England
and Scotland, UK], CEU [Utah residents with ancestry from
northern and western Europe from the CEPH collection], and
TSI [Toscans in Italy]), and Asian ancestry (CHS [Han Chinese
South, China], CHB [Han Chinese in Beijing, China], and JPT
[Japanese in Tokyo, Japan]) from HapMap40 and the 1,000
Genomes Project.41 For these population samples, the haplotype
analyses were based on all of the 28 SNP positions.Haplotype Evolution Analysis
We used data from primates and archaic hominins to examine the
evolutionary history of haplotypes A and D (see Table S2). For
chimpanzees, we obtained sequence variants from in-house
whole-genome sequence data on the SOLiD 3 system. Two indi-
viduals were sequenced at 73 and 133 coverage, respectively,
and the reads were aligned to the chimpanzee reference sequence
(panTro2). The Denisovan sequence originates from high-
coverage Illumina sequencing (303) of a finger bone from one
individual in a recently discovered archaic hominin group.42
The Neanderthal sequence variants were inferred from Illumina
sequencing of bones from three different individuals (Vi33.16,
Vi33.25, and Vi33.26).43Age Estimate of Haplotype D
Our estimate of the age of haplotype D is based on a 30 kb region
(chr11: 61,324,000–61,354,000) with low heterozygosity in HGDP
populations in Africa and America (see Figure S3). As a proof of
concept, we first aimed at determining the mutation rate in the
FADS region on the basis of a human-chimpanzee comparison.
Therefore, we aligned SOLiD mate-pair reads from two chimpan-
zees to the human reference sequence (hg18) and identified fixed
nucleotide differences. The alignment and variant calling were
done by two different strategies; the first was with Bioscope and
diBayes software, and the second was with Mosaik and
SAMtools.44 We required the variants to be detected by both
methods. This analysis revealed 154 nucleotide differences within
the 30 kb window for one of the chimpanzees and 100 nucleotide
differences for the other. The chimpanzee with the higher number
of nucleotide differences was sequenced at 133 coverage
compared to 73 coverage for the other individual. The correlation
between coverage and number of identified variants indicates that
some of the nucleotide differences in one of the chimpanzees were
not detected because of insufficient coverage. We therefore used
the higher number of variants (154) as a measurement of the
number of fixed nucleotide differences between humans and
chimpanzees. Assuming that 154 mutations have accumulated
on the human and chimpanzee lineages since the time of the
last common ancestor about 5 million years ago and assuming
an average generation time of 20 years, the mutation rate for the
region was estimated at 1.033 108 mutations per base per gener-
ation. Our mutation rate is very similar to the estimate from
a recent whole-genome sequencing study of a family quartet; in
this study, the intergeneration mutation rate was estimated at
~1.1 3 108 per position.45
SNP information in the 30 kb region was extracted for seven
human individuals that have been sequenced at high coverage;erican Journal of Human Genetics 90, 809–820, May 4, 2012 811
Figure 1. LD Pattern in the FADS Region
LD display of the five population cohorts from
Sweden (NSPHS), Scotland (ORCADES), The
Netherlands (ERF), Croatia (VIS), and Italy
(MICROS) (left) and of all individuals combined
(bottom right). Color schemes in all LD maps are
based on the standard (D’/LOD) option in the
Haploview software. The genomic coordinates
on chromosome 11 (hg18) are shown at the top
right, and the locations of eight SNPs are drawn
out as positional guides. The vertical black bars
show p values for each individual SNP; p values
range from 1 to 1075 and represent the associa-
tion with the lipid PC 36:4. See Table S1 for a
complete list of p values for all SNPs in the region.five of these individuals have a DD genotype, and two have a AA-
genotype. The five DD individuals are all fromAfrica; KB1 and ABT
are from Southern Africa,46 NA19238 and NA19293 are the
parents from a YRI trio sequenced as part of the 1,000 Genomes
Project,41 and NA18507 is a HapMap individual also from YRI.
The two individuals with the AA genotype are one Paleo-Eskimo
(Saqqaq)47 and one Australian Aboriginal.48 We calculated
the pair-wise nucleotide differences between all seven human
samples, the Denisovan sample, and the 133 chimpanzee sample,
and we applied the UPGMA (unweighted pair-group method of
analysis) hierarchical clustering as implemented in the phangorn
R package.49 The phylogenetic analysis revealed two distinct clus-
ters on the human lineages, one with the individuals homozygous
for haplotype A and the other with individuals homozygous for
haplotype D. We then counted the number of mutations—within
each of the DD and AA clusters—that are not present in other
branches in the tree. On average, there were 8.4 nucleotide differ-
ences between individuals within the DD group and 20 nucleotide
differences between individuals within the AA cluster. From
these numbers of mutations, we estimated a divergence time of
255,000 years ago for haplotype D and 606,000 years ago for
haplotype A. We also performed similar calculations on the basis
of the minimum and maximum number of nucleotide differences
within the DD group, and this calculation resulted in a range from
212,000 to 303,000 years ago. In these calculations, we assumed
a mutation rate of 1.03 3 108 mutations per base per generation
(as estimated above) and an average generation time of 20 years.
Furthermore, we used the Bayeseanmethod BEAST50 as an alter-
native approach to estimate divergence times, and this resulted
in an age of 433,000 years ago for haplotype D. One plausible
explanation for the discrepancy is that the BEAST program
overestimated the age because of input data. BEAST requires the
two haploid FADS sequences from each individual as input, and
it is impossible to deduce these sequences from the short read
data. As a result, the program cannot distinguish between
homozygous and heterozygous positions. This probably leads to
an overestimate because all variant nucleotides (present in a
heterozygous state as is the case for the individuals carrying the
haplotype D in the study) are assumed to be present on the
same haplotype.812 The American Journal of Human Genetics 90, 809–820, May 4, 2012Results
Two Common FADS Haplotypes
To determine the haplotype structure in the
FADS region, we used SNP-array genotypedata from 5,652 individuals from five European local
population cohorts (EUROSPAN) and data from the 1,000
Genomes Project41 to impute additional SNPs, and we
phased the chromosomes. The combined data for the
five populations showed the presence of twomajor linkage
disequilibrium (LD) blocks, one spanning FADS1 and
the first part of FADS2 (block 1) and another spanning
the second part of FADS2 (from exon 6 to the 50UTR)
(block 2) (Figure 1). The same LD pattern was found in
all five European cohorts.
We studied the association between these blocks and
lipid levels by using a lipid (phosphatidylcholine [PC]
36:4) measured in our five European population cohorts.
A meta-analysis of the individuals with the highest and
lowest levels of this lipid (n ¼ 952) showed that the most
significant SNP associations (p < 1060) were located in
block 1 (see Figure 1 and Table S1). We used phased chro-
mosome data to identify in block 1 a set of 28 SNPs
(Table S2) that most clearly distinguished the two groups
of individuals with high and low lipid levels. A similar
analysis for block 2 did not produce a strongly associated
set of SNPs (data not shown). Because of this and the fact
that the p values were considerably lower in block 1 than
in block 2 (see Figure 1), we focused our attention on
block 1. The two main haplotypes identified on the basis
of the 28 SNPs in block 1 accounted for over 95% of the
chromosomes in the five populations; the remaining chro-
mosomes could be accounted for by a set of rare haplotypes
that were combinations of the two major ones (Table 1).
The most common haplotype, denoted haplotype D, was
associated with high lipid levels (p ¼ 1 3 1065), whereas
the less common haplotype (haplotype A) was associated
with low levels (p ¼ 1 3 1052).
To determine whether there could exist in block 1
other strongly associated haplotype structures that were
obscured by the presence of haplotypes A and D, we
removed the 28 SNPs from the input data and repeated
Table 1. Frequency of FADS Haplotypes in European Populationsa
Haplotype
SNP
Frequency (%) Association (p Value)1234567890123456789012345678
D CCCTCGTTAATCTTAAAAACCACCCTAG 62.1 1 3 1065
A agtcgaccggctccgggggttgaaaaga 33.0 1 3 1052
M1 CgtcCGccggTCTTggAggttgaaaaga 2.8 3 3 1004
M2 agtcgaccggctccgggggttgaCaaga 0.5 9 3 1002
M3 agtcgaccggTtccgggggttgaaaaga 0.3 2 3 1001
M4 CCCTCGTTAATCTTAAAAACCgaaaaga 0.2 4 3 1002
Total frequency 98.9
The haplotypes are defined by 28 SNPs in block 1. The association between FADS haplotypes and lipid levels (PC 36:4) in the five European cohorts is shown in the
far right column. Nucleotides on haplotypes D and A are represented by uppercase and lowercase letters, respectively.
aFrom the European Special Population Research Network (EUROSPAN).the same analysis procedure for the remaining SNPs in
block 1. This resulted in a haplotype consisting of only
two SNPs (rs174541 and rs174583). These two SNPs were
in very strong LD with the previously identified 28 SNPs.
Our analysis thus revealed that in block 1, there were addi-
tional significant SNPs that would have been included
among the set of 28 if slightlymore relaxed filtering criteria
had been used. However, in block 1, there are no other
independent haplotypes that have strong association
with PC 36:4.
To investigate the effect of SNPs not present on the
genotyping arrays or in the 1,000 Genomes Database, we
designed amplicons for the FADS region and performed
deep sequencing by using the SOLiD system in two
pools of individuals from each of our five populations
(Figure S1). Each pool consisted of a minimum of 90 indi-
viduals with either the highest or lowest levels of PC 36:4.
From the targeted resequencing, we identified a number of
additional variants, but none of these showed as large
a difference in frequency between the extreme lipid groups
as the 28 SNPs previously found to distinguish haplotypes
A and D, described above. However, by applying the
C-alpha test38 for analyses of rare variants in high-
throughput sequencing data, we detected in the FADS
region several low-frequency SNPs that differed signifi-
cantly between the high- and low-lipid pools (Table S3).
Genotyping of 14 of the significant low-frequency SNPs
in 1,308 individuals showed that all of them were predom-
inantly located on haplotype A (Table S4). No association
was seen for any of the 14 SNPs when the analysis was
adjusted for the effects of haplotypes A and D. Our
analyses thus show that the association of SNPs with lipid
levels can be entirely explained by the two common
haplotypes and that there is no independent effect of
rare variants.
Effect of FADS Haplotypes on PUFA Metabolism
We studied the functional difference between the two
haplotypes by measuring the levels of eight PUFAs in theThe Amomega-3 and omega-6 pathways in blood plasma from
the NSPHS cohort (Table 2). In both the omega-3 and
omega-6 pathways, haplotype D was strongly associated
with lower levels of the precursors in fatty-acid synthesis
(LA and ALA) and higher levels of EPA, GLA, DHA, and
AA (the products), indicating that this haplotype is more
efficient in converting the precursors to LC-PUFAs (Figure 2
and Table 2). Individuals homozygous for haplotype D had
24% higher levels of DHA and 43% higher levels of AA
than those homozygous for haplotype A. Analysis of the
ratios of consecutive products in fatty-acid synthesis (i.e.,
GLA/LA, ETA/ALA, AA/DGLA, and EPA/ETA) showed that
both the d-5 and d-6 desaturase steps are affected by the
FADS haplotype (Table 2).
The conversion of ALA to DHA occurs primarily in the
liver,51 and the examination of gene-expression levels in
liver samples from 195 individuals52 showed that individ-
uals homozygous for haplotype D have significantly
higher expression of FADS1 than those homozygous for
haplotype A (see Figure S2). This finding is further sup-
ported by results from databases, e.g., the eQTL browser,
and other publications,53 in which SNPs within this region
have been shown to affect the transcription levels of both
FADS1 and FADS2. The increase in expression level by
haplotype D in liver agrees with the effect that we esti-
mated for haplotype D on the FADS catalyzed steps in
fatty-acid synthesis and the generation of LC-PUFAs (Table
2). Thus, the two FADS haplotypes differ both in transcrip-
tion levels and in their ability to synthesize AA and DHA
from their precursors.
The 28 SNPs defining haplotypes A and D span a 38.9 kb
region, including the promoter regions of FADS1 and
FADS2. Given that we have performed a comprehensive
genetic analysis of the region, the difference in the haplo-
types’ ability to synthesize LC-PUFAs is probably due to
one or several of the 28 SNPs that define the haplotypes
or, possibly, some nearby genetic variant(s) in LD. Deter-
mining which SNP(s) is causative is difficult because of
the complete LD in the region, but the fact that severalerican Journal of Human Genetics 90, 809–820, May 4, 2012 813
Table 2. Associations between FADS Haplotypes and PUFAs in the
NSHPS Cohort
Common
Name
p Value
(mmscore)a
Effect of
Haplotype D
Omega-6
FA18:2(n-6) LA 0.052 0.12
FA18:3(n-6) GLA 1.3 3 1018 0.56
FA20:3(n-6) DGLA 0.26 0.07
FA20:4(n-6) AA 5.2 3 1018 0.50
Ratio GLA/LAb 1.6 3 1027 0.68
Ratio AA/DGLAb 1.8 3 1011 0.40
Omega-3
FA18:3(n-3) ALA 0.024 0.14
FA20:4(n-3) ETA 2.2 3 1005 0.25
FA20:5(n-3) EPA 1.1 3 1012 0.37
FA22:6(n-3) DHA 8.3 3 1005 0.20
Ratio ETA/ALAb 0.042 0.12
Ratio EPA/ETAb 1.0 3 1024 0.61
The p values represent significance of differences in PUFA levels and have been
corrected for relatedness between individuals. The following abbreviations are
used: LA, linoleic acid; GLA, gamma-linoleic acid; DGLA, dihomo-gamma-lino-
leic acid; AA, arachidonic acid; ALA, alpha-linoleic acid; ETA, eicosatetraenoic
acid; EPA, eicosapentaenoic acid; and DHA, docosahexaenoic acid.
aMixed model to adjust for relatedness among individuals; Bonferroni-adjusted
p values.
bRatios (product/substrate) for the FADS1- or FADS2-catalyzed steps in fatty-
acid synthesis.
Figure 2. Effect of Haplotype on Synthesis of PUFAs in the
Omega-3 and Omega-6 Pathways
Measurements of the omega-3 and 6 fatty-acid levels in the NSPHS
population. The three bars in each of the smaller plots (labeled
DD, DA, and AA) represent levels of fatty acids in individuals
homozygous (AA and DD) and heterozygous (DA) for the A and
D haplotypes. Fatty-acid measurements have been scaled so
that the average levels for the individuals homozygous for haplo-
type A are set to 1. The error bars represent the upper and lower
quartiles for the PUFA measurements. Asterisks (*) indicate
p values < 103.of the SNPs that define the two haplotypes are located at
sites where complexes with regulatory molecules have
been shown to bind (Figure 3) advocates for a functional
significance of one or several of the SNPs in the haplotype
block on the transcription levels.
Population Distribution and Diversity of FADS
Haplotypes
Estimated from the human genome diversity panel
(HGDP-CEPH),39 the geographic distributions of haplo-
types A and D differ dramatically between continents
(Figures 4A and 4B). In African HGDP populations, haplo-
type A is essentially absent (1% of chromosomes), whereas
in Europe, West, South, and East Asia, and Oceania, it
occurs at a frequency of 25%–50%. Among the 126 Native
Americans included in HGDP, haplotype A accounts for
97% of the chromosomes. A complementary analysis of
haplotype frequencies for population samples from
HapMap40 and the 1,000 Genomes Project41 confirmed
that haplotype A occurs at a very low frequency among
individuals of African descent, whereas it is present at
moderate to high frequencies in populations of European
and Asian ancestry (Figure 4C). Among individuals of
African ancestry, 49% carry mixed FADS haplotypes with
a higher resemblance to haplotype D than to haplotype
A, consistent with a decay of haplotype D by recombina-
tion in African populations (Figure 4C).814 The American Journal of Human Genetics 90, 809–820, May 4, 2Signature of Positive Selection
The very high frequency of haplotype D in Africa and the
high LD in the FADS region indicate that this part of the
genome has been subjected to positive selection, and this
is supported by several lines of evidence from the HGDP
data.39 African and American populations show a large
reduction in heterozygosity in a 30 kb region encompass-
ing the FADS haplotypes (see Figure S3). The cross-popula-
tion extended haplotype homozygosity test (XP-EHH),
which is designed to detect selective sweeps where the
selected allele has approached or achieved fixation in one
population but remains polymorphic in the human
population as a whole,54 shows a distinct peak in the
FADS region in the African Bantu-speaking populations
(Figure S3C). Moreover, in a genome-wide analysis that
used a composite likelihood ratio (CLR) test of the allele-
frequency spectrum,55,56 the FADS region is among the
top five candidate-gene clusters that have been under posi-
tive selection in African populations.57
Evolutionary History of the FADS Region
Comparative-genomics analyses focusing on the 28 SNPs
that distinguish haplotypes D and A showed that rhesus
macaques, African apes (chimpanzees and gorillas), and
Denisovans42 all have haplotypes that are very similar to
haplotype A (Figure 5A and Table S2). The Neanderthal
data are based on incomplete sequences from three indi-
viduals43 and have nucleotide variants found on both
human haplotypes, but overall, they have higher similarity012
Figure 3. Transcriptional Regulation Elements in the FADS Region
The figure shows a UCSC Genome Browser view of the FADS region; the 28 SNPs define the two haplotypes A and D indicated in red (at
the top). The two tracks in the middle show promoter- and enhancer-associated histone marks identified in cell-line studies within the
ENCODE project.65 Below is a track displaying transcription-factor binding in the region as identified by ENCODE ChIP-seq experi-
ments. The track at the bottom shows the binding profile for the transcription factor SREBP1 in HepG2 cells; this protein has been shown
to affect expression of both FADS1 and FADS2 in mice.66 Many of the SNPs that distinguish haplotype A from D are located inside or in
close proximity to the binding sites of regulatory molecules.to haplotype A. Our results thus indicate that haplotype D
appeared on the lineage leading to modern humans.
Intriguingly, the distance between FADS1 and FADS2 has
been reduced (though a deletion) from over 75 kb in rhesus
macaques and chimpanzees to only 11 kb in humans. This
deletion brought the promoters of FADS1 and FADS2 closer
to each other, and this might have resulted in coordinated
regulation of FADS expression.
In order to further understand the evolutionary history
of haplotypes A and D, we focused on the 30 kb region
of the FADS haplotypes with reduced heterozygosity, and
we made use of the data from high-coverage whole-
genome sequencing of five African individuals that were
all homozygous for haplotype D40,46 and two individuals,
one Palaeo-Eskimo47 and one Australian Aboriginal,48
who were both homozygous for haplotype A. For compar-
ison, we also obtained data from a Denisovan and a chim-
panzee sequenced at high coverage. For the seven humans,
the Denisovan, and the chimpanzee, we then computed all
pair-wise nucleotide differences within the 30 kb window
and performed a hierarchical clustering by using UPGMA.
The results show two clusters in humans, one in which
the five African individuals carry the DD genotype and
another in which the Eskimo and the Aboriginal carry
the AA genotype (Figure 5B). On the basis of the number
of SNPs that have accumulated between the DD genotypes,
we estimated an age of 255,000 years (range: 212–303
years) for haplotype D diversity. Similarly, based on the
variability between AA genotypes, an estimate for haplo-
type A is an age of 606,000 years. Furthermore, we usedThe Amthe BEAST software50 to analyze the evolutionary history
of the haplotypes, and this resulted in an estimate
of 433,000 years for the age of haplotype D. Because
we were unable to reconstruct the complete haploid
sequences that are required as input for BEAST (see
Material andMethods), the estimates produced by UPGMA
might be more accurate, and the BEAST results should be
seen as an upper limit. Our results thus show that haplo-
type D appeared after the split from Neanderthals (around
500,000 years ago) but prior to the exodus of modern
humans from Africa (50,000–100,000 years ago).Discussion
Single genetic variants in the FADS1 and FADS2 region
have previously been associated with lipid-related traits
and phenotypes. Our analysis shows the presence of two
common human haplotypes with dramatic differences
in transcription levels and the ability to synthesize essen-
tial omega-3 and omega-6 LC-PUFAs (e.g., AA and DHA).
These two haplotypes account for all of the genetic
effect seen in FADS activity, and none of the rare SNPs in
the region appear to have any additional effect. Haplotype
D, which is associated with increased FADS activity, is
specific to humans and has appeared on the lineage
leading to modern humans well after the split from the
common ancestor of humans and chimpanzees. Given
that haplotype D has few similarities with the Neanderthal
sequences, it does not appear that this human haplotypeerican Journal of Human Genetics 90, 809–820, May 4, 2012 815
Figure 4. Distribution of FADS Haplotypes in Human Populations
(A) The frequencies of the A (blue) and D (red) haplotypes on different continents are based on four SNPs genotyped in the HGDP pop-
ulations. The remaining fractions represent mixes (gray) of haplotypes A and D. In Europe, data for the same four SNPs are included for
all genotyped individuals in our five local population cohorts (EUROSPAN).
(B) Frequencies of A, D, and mixed haplotypes in HGDP populations in which at least ten individuals have been genotyped.
(C) Frequencies of the 28 SNPs on the FADS haplotypes for tenHapMap and 1,000Genomes populations of African, European, and Asian
ancestry. Phased SNP data for all chromosomes in a population are shown as colored rows. Each row consists of 28 elements, one for each
SNP on the two main haplotypes. A SNP is colored blue if it is located on haplotype A and colored red if it is on haplotype D. Mixed
haplotypes are represented by horizontal lines that contain both red and blue elements.has been acquired from an archaic species, as proposed for
some HLA alleles,58 but that it has evolved on the lineage
leading to modern humans.
The age of the diversity seen in haplotype D and the
present geographic distribution of this haplotype indicate
that both haplotype A and haplotype D were present in
Africa at the time of the exodus of modern humans
50,000–100,000 years ago; therefore, both haplotypes(B) Dendrogram—resulting from a hierarchical clustering via the U
region between five DD individuals, two AA individuals, the Denov
branches, and DD genotypes are depicted with red branches.
816 The American Journal of Human Genetics 90, 809–820, May 4, 2were present in European, Asian, and Oceanian popula-
tions. The low frequency of haplotype D in the Native
American populations included in HGDP indicates that
this haplotype might have been lost because of a bottle-
neck effect in the colonization of the American conti-
nent,59,60 possibly in combination with relaxation of the
selective pressure as a result of a diet higher in essential
LC-PUFAs. It is also possible that haplotype D is moreFigure 5. Evolution of FADS Haplotypes
(A) The 28 SNPs distinguishing the two main
haplotypes in modern humans are shown at the
bottom (haplotype A in red letters, D in blue),
and the corresponding nucleotides in primates
and archaic hominins are aligned above. The
nucleotides for rhesus macaques, gorillas, and
chimpanzees are taken from their respective
reference genomes (rheMac2, gorGor3, and pan-
Tro2). Positions marked by hyphens are missing
from the reference assemblies and probably
represent deletions. For the archaic hominins,
all nucleotides identified by at least ten reads
(Denisovan) and two reads (Neanderthal) by
Illumina sequencing are shown (see Table S2 for
detailed data). Empty cells indicate positions
with no sequence-read information as a result
of either insufficient coverage or a deletion.
PGMA method—of pair-wise nucleotide differences in the FADS
isan, and one chimpanzee. AA genotypes are depicted with blue
012
common in other populations on the American continent.
In Africa, haplotype D appears to have continued to
increase in frequency after the exodus until it reached
the present dominating position. Consequently, in the
FADS region today, the derived allele (haplotype D) is
more frequent in Africa than in other continents; this
finding contrasts the more common pattern in which the
ancestral allele is more frequent in Africa. Consistent
with our results, it has been shown that FADS genetic vari-
ants have a stronger effect on PUFA metabolism in African
Americans than in Americans of European descent as
a result of differences in genotype frequencies.61
We can only speculate about the mechanisms respon-
sible for the increase in frequency of haplotype D. The
very rapid increase in the brain size of hominoids probably
involved selection on a number of loci and was initiated
prior to the appearance of Homo erectus. Such an increase
must have resulted in a greater need for LC-PUFAs so
that the larger brain volume could be supported. It has
been proposed that a shift in diet, characterized by access
to food sources that are rich in essential LC-PUFAs, was
initiated about 2 million years ago.1,19 This change in the
availability of LC-PUFAs might have been important for
maintaining the proportionally large hominoid brain rela-
tive to body size. Our estimate of the age of haplotype D
predates the earliest known anatomically modern humans
at about 200,000 years old. The appearance of haplotype D
probably did not have any direct effect on brain size per se
but might have been selected for because it was highly
advantageous under certain circumstances. Humans use
a very large portion of dietary fats, predominantly AA
and DHA, to feed the brain.1 Consequently, humans’
ability to more efficiently synthesize LC-PUFAs from their
precursors might have played an important role their
ability to survive in periods during which AA- and DHA-
rich diets were not available. Haplotype D is likely to
have been advantageous to humans living in environ-
ments with a limited access to these fatty acids, and this
could explain the signature of positive selection seen for
this haplotype in African populations.
Regarding the present diet in the Western world, the
advantage of having a faster biosynthesis of LC-PUFAs
for carriers of haplotype D might have turned into a
disadvantage. Because haplotype D increases the biosyn-
thesis of both omega-3 and omega-6 LC-PUFAs, high
intake of omega-6 LC-PUFAs augments the amount of
AA and thereby the synthesis of arachidonic-acid-derived
proinflammatory eicosanoids, which are associated with
increased risk of atherosclerotic vascular damage.62 Thus,
we hypothesize that the acquisition of a FADS haplo-
type—which might have been beneficial when food sour-
ces rich in the essential LC-PUFAs were in limited supply
and when humans had to rely on vegetable oils containing
precursors of these fatty acids—would now act as a thrifty
genotype and represent a risk factor for lifestyle-related
diseases, such as coronary artery disease.18 Consistent
with this hypothesis, it has been suggested that differencesThe Amin the capacity to synthesize LC-PUFA might contribute to
health disparities between populations of African and
European descent63 and that FADS genotyping should be
included as a diagnostic for dietary recommendations.64
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